In Florida, Akron Biotechnology, LLC joined the New Hampshire based Manufacturing USA initiative, called the Advanced Regenerative Manufacturing Institute, to help develop and manufacture tissue and organs. The ARMI initiative is comprised of almost 100 organizations and includes $80 million in funding from the federal government and over $200 million from industry organizations, academic institutions, and non-profits. The program’s network invests in leading manufacturing and biofabrication technologies as well as biomaterial and cell processing for the Department of Defense. Their goal is to grow American manufacturing and incentivize companies to invest within the United States to move forward and improve biofabrication technology especially for cells, organs and tissue.
Home Biomaterials No Need to Wait for Organ Transplant? Organ and Tissue Manufacturing Initiative...
Latest article
Not PLA‑ying dead: Bioplastic skulls replace gory antler mounts
In Utah, Bucks N Bull Skulls is using bioplastic polylactic acid filament to 3-D print animal skulls for mounting antlers – an alternative that...
Funding flatlines: Meatable closes up shop
In the Netherlands, cultivated meat pioneer Meatable has failed to secure sufficient funding and is winding down operations. The company had been operating a...
“Sound” investment: Biobased acoustic panel maker Aisti receives €20 million EIB loan
In Finland, sustainable acoustics products firm Aisti has received a €20 million (US$23.4 million) loan from the European Investment Bank to scale production of...